T cells from patients with Parkinson's disease recognize α-synuclein peptides.
about
Alpha-Synuclein to the Rescue: Immune Cell Recruitment by Alpha-Synuclein during Gastrointestinal Infection.A novel panel of α-synuclein antibodies reveal distinctive staining profiles in synucleinopathies.The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases.Vertebrate food products as a potential source of prion-like α-synuclein.HLA Class I or Class II and Disease Association: Catch the Difference If You Can.α-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration.α-Synuclein-Dependent Calcium Entry Underlies Differential Sensitivity of Cultured SN and VTA Dopaminergic Neurons to a Parkinsonian Neurotoxin.Neuroinflammation: Microglia and T Cells Get Ready to Tango.Erratum: T cells from patients with Parkinson's disease recognize α-synuclein peptides.Inflammation in CNS Neurodegenerative Diseases.Measurements of auto-antibodies to α-synuclein in the serum and cerebral spinal fluids of patients with Parkinson's disease.Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease.The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease.HLA variation and disease.Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration.Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease.Abnormalities of age-related T cell senescence in Parkinson's disease.Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration.Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease.Induction of the Immunoproteasome Subunit Lmp7 Links Proteostasis and Immunity in α-Synuclein Aggregation Disorders.Emerging Biosensing Technologies for Neuroinflammatory and Neurodegenerative Disease Diagnostics.Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease.CD4 T cells react to local increase of α-synuclein in a pathology-associated variant-dependent manner and modify brain microglia in absence of brain pathology.Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients.Monocyte Function in Parkinson's Disease and the Impact of Autologous Serum on PhagocytosisA Systematic Review and Meta-Analysis of Alpha Synuclein Auto-Antibodies in Parkinson's DiseaseTh17 lymphocyte spearheads the immune attack in Parkinson's disease: New evidence for neuronal deathα-Synuclein and Noradrenergic Modulation of Immune Cells in Parkinson's Disease PathogenesisMicroglia Response During Parkinson's Disease: Alpha-Synuclein InterventionInterplay Between the Unfolded Protein Response and Immune Function in the Development of Neurodegenerative Diseases
P2860
Q40060108-50F24225-4148-48E7-9D02-DF1E8ACF3982Q41069719-B2528EEB-70BA-4D24-A028-91D8057B1A9DQ42617618-36CF32EA-02E6-4ECF-90FE-1CC45B57F45DQ46252338-BB884E2B-E2C2-4991-85D4-4E253B7E5244Q47111038-58388A59-A777-49CB-9981-73C5E1CADC06Q47127566-93E70BCA-D096-40C4-B979-FFE48F335A9CQ47135899-7A4DBE27-C48D-41A0-BC7B-026C3AFED32EQ50106151-8D4C9042-7139-4088-AE30-95734703B5A3Q50107487-F119005F-3E7A-467F-B29F-DA6130924AC7Q51765219-25A9EE10-8E59-42BD-AEAF-901E838D2012Q51766023-206CC73A-9DA8-4EC3-B22A-14E8B3AB7DD3Q52592689-1882B479-C378-41BF-9ECB-0CF07BA11C9EQ52649972-2ACD263B-DD23-47FC-B24E-3352A15A9A7BQ52732932-BB3709E2-0F8A-48CF-8570-A1EFDDE360D9Q54486835-2F41ACB7-2C23-4881-A939-D673A0EECDBCQ55048859-B1EB6AFC-9408-4AA1-A57E-DD8146B5D7DDQ55078392-49A2D0EB-B27B-4C14-9DA9-52F1FF8D9CB4Q55152170-758D7613-9963-4BF8-A897-8784427A3EE6Q55240777-5C87E9FE-CDA2-4A83-AA53-52D750F26E54Q55305758-28146D94-BAD3-4037-BEE2-0C872A685CF3Q55379242-394A1896-F8CD-4E25-A032-891951C2C0BDQ55387411-99237063-EF02-4A35-B9D8-465F827F5FF9Q55546710-3AE7518E-6EFB-487C-A50C-77F32084DF50Q55715822-734A3D4B-4316-470D-BEBE-7742824A93E6Q58553983-FE00F2BD-5E7C-4EA3-884D-0A40C6156C0CQ58592665-E639655E-5F9D-4307-8604-B995A2BC4BA2Q58598716-4A9BD7E2-48F9-4768-993C-0EE41C63C8D2Q58750079-4C2A5024-27E0-4ACB-B3DF-2DF72C3CD539Q58799080-828530EF-BF53-474D-8ECF-F6CAD23E0AFCQ59132127-0A10C843-B31C-4EEF-A9FB-80C0C8C66679
P2860
T cells from patients with Parkinson's disease recognize α-synuclein peptides.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
T cells from patients with Parkinson's disease recognize α-synuclein peptides.
@en
type
label
T cells from patients with Parkinson's disease recognize α-synuclein peptides.
@en
prefLabel
T cells from patients with Parkinson's disease recognize α-synuclein peptides.
@en
P2093
P2860
P50
P356
P1433
P1476
T cells from patients with Parkinson's disease recognize α-synuclein peptides.
@en
P2093
April Frazier
Carla Oseroff
Chelsea Carpenter
Christopher Liong
Curtis McMurtrey
Ellen Kanter
Francesca Garretti
John Sidney
Julian Agin-Liebes
P2860
P2888
P304
P356
10.1038/NATURE22815
P407
P50
P577
2017-06-21T00:00:00Z